Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Running, not enrolling · Not applicable

Conditions studied: Ischemic Stroke, Systemic Embolism

In brief

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Key facts

Study ID
NCT05478304
Run by
AtriCure, Inc.
People needed
6573
Starts
2023-01-25
Expected to finish
2032-04-01
Last updated by the study team
2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.